Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

3.34B

Market cap3.34B

Price-Earnings ratio

67.74

Price-Earnings ratio67.74

Dividend yield

—

Dividend yield—

Average volume

864.76K

Average volume864.76K

High today

$53.97

High today$53.97

Low today

$50.60

Low today$50.60

Open price

$51.30

Open price$51.30

Volume

935.40K

Volume935.40K

52 Week high

$60.60

52 Week high$60.60

52 Week low

$28.96

52 Week low$28.96

PTGX News

Simply Wall St 11h

Exploring Three High Growth Tech Stocks In The US Market

The United States market has shown a positive trend, climbing 1.4% in the last week and rising 12% over the past year, with earnings projected to grow by 15% an...

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.